AI assistant
MEDIFAST INC — Director's Dealing 2022
Jan 4, 2022
33899_dirs_2022-01-04_d188d6d6-2cbf-4b5a-bf51-a13f214aa38c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2021-12-31
Reporting Person: Chard Daniel R (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | Common Stock | M | 24072 | — | Acquired | 39788 | Direct |
| 2021-12-31 | Common Stock | F | 11533 | $209.43 | Disposed | 28255 | Direct |
| 2022-01-03 | Common Stock | G | 12539 | — | Disposed | 15716 | Direct |
| 2022-01-03 | Common Stock | G | 12539 | — | Acquired | 103149 | Indirect |
Footnotes
F1: 12,036 Performance Stock Units were granted on February 20, 2019, and vested on December 31, 2021 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors.
F2: The reporting person transferred these shares to The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
F3: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.